Seeking Alpha

  Progenics Pharmaceuticals Inc. - NASDAQ

11/28/2014, 12:02 PM ET
  • StockConsultant | Send Message 8 Jan

    $PGNX price gap above 6.4 breakout area, big volume +261% norm,
      PGNX vs. ETF Alternatives
      Company Description
      Progenics Pharmaceuticals Inc is engaged in the development of medicines for oncology .It develops products for the treatment of prostate cancer, for the treatment of opioid-induced constipation, or OIC, as well as OIC for non-cancer pain.
      Sector: Healthcare
      Industry: Biotechnology
      Country: United States